FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1974802912> ?p ?o ?g. }

• W1974802912 endingPage "49" @default.
• W1974802912 startingPage "46" @default.
• W1974802912 abstract "During the past decade, the incidence of end-stage renal disease (ESRD) has risen dramatically, primarily due to an increase in the incidence of diabetes. In patients with diabetes, both hyperglycemia and hypertension are independent risk factors for renal disease. Hypertension is also a risk factor in nondiabetic renal disease and contributes to renal dysfunction by increasing glomerular pressure, glomerular capillary damage, and proteinuria. The resultant nephron damage increases glomerular pressure and damage within remnant functional nephrons, further contributing to deterioration of renal function. In addition to its role in systemic hypertension, angiotensin II has direct effects on the kidney through elevation of glomerular capillary pressure and upregulation of components of the renal injury response. These direct effects of angiotensin II on the kidney support the inclusion of agents that target the renin-angiotensin system (RAS) into treatment regimens for patients at risk for renal disease. Several clinical trials have established the benefits of angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) in patients with diabetes. The ACE inhibitors have been shown to delay renal decline in patients with type 1 diabetes, whereas the renoprotective effect of these agents in patients with type 2 diabetes is less clear. The ARBs have been shown to provide significant benefits in patients with type 2 diabetes, both at early (microalbuminuria) and late (proteinuria) stages of renal decline. In the Irbesartan Diabetic Nephropathy Trial (IDNT) and the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) study, ARB therapy significantly reduced the progression of overt nephropathy (composite of doubling of serum creatinine, ESRD, and death), a benefit that has not been shown for ACE inhibitors. Moreover, in RENAAL, losartan significantly reduced the incidence of the individual end point of ESRD. The benefits of ARB therapy in IDNT and RENAAL were associated with significant reductions in proteinuria and were independent of blood pressure reductions. In RENAAL, proteinuria was a strong predictor of both renal and cardiovascular events. These findings underscore the importance of RAS blockade as a strategy for improving clinical outcomes in patients with renal disease." @default.
• W1974802912 created "2016-06-24" @default.
• W1974802912 creator A5026732428 @default.
• W1974802912 date "2003-11-01" @default.
• W1974802912 modified "2023-09-26" @default.
• W1974802912 title "Recommendations for the management of special populations: renal disease in diabetes" @default.
• W1974802912 cites W1968446955 @default.
• W1974802912 cites W1975768263 @default.
• W1974802912 cites W1988962204 @default.
• W1974802912 cites W1998434576 @default.
• W1974802912 cites W2008426639 @default.
• W1974802912 cites W2040299750 @default.
• W1974802912 cites W2044773944 @default.
• W1974802912 cites W2056976690 @default.
• W1974802912 cites W2105767342 @default.
• W1974802912 cites W2118286022 @default.
• W1974802912 cites W2615684303 @default.
• W1974802912 cites W2769264260 @default.
• W1974802912 cites W2993043209 @default.
• W1974802912 cites W2003670762 @default.
• W1974802912 cites W2068447256 @default.
• W1974802912 cites W2319268509 @default.
• W1974802912 doi "https://doi.org/10.1016/j.amjhyper.2003.07.006" @default.
• W1974802912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14625161" @default.
• W1974802912 hasPublicationYear "2003" @default.
• W1974802912 type Work @default.
• W1974802912 sameAs 1974802912 @default.
• W1974802912 citedByCount "27" @default.
• W1974802912 countsByYear W19748029122014 @default.
• W1974802912 countsByYear W19748029122020 @default.
• W1974802912 countsByYear W19748029122021 @default.
• W1974802912 countsByYear W19748029122023 @default.
• W1974802912 crossrefType "journal-article" @default.
• W1974802912 hasAuthorship W1974802912A5026732428 @default.
• W1974802912 hasBestOaLocation W19748029121 @default.
• W1974802912 hasConcept C126322002 @default.
• W1974802912 hasConcept C126894567 @default.
• W1974802912 hasConcept C134018914 @default.
• W1974802912 hasConcept C159641895 @default.
• W1974802912 hasConcept C2776174234 @default.
• W1974802912 hasConcept C2777180221 @default.
• W1974802912 hasConcept C2778653478 @default.
• W1974802912 hasConcept C2779561371 @default.
• W1974802912 hasConcept C2779922275 @default.
• W1974802912 hasConcept C2780091579 @default.
• W1974802912 hasConcept C2780259554 @default.
• W1974802912 hasConcept C2780288358 @default.
• W1974802912 hasConcept C2781184683 @default.
• W1974802912 hasConcept C2908929049 @default.
• W1974802912 hasConcept C555293320 @default.
• W1974802912 hasConcept C71924100 @default.
• W1974802912 hasConcept C84393581 @default.
• W1974802912 hasConceptScore W1974802912C126322002 @default.
• W1974802912 hasConceptScore W1974802912C126894567 @default.
• W1974802912 hasConceptScore W1974802912C134018914 @default.
• W1974802912 hasConceptScore W1974802912C159641895 @default.
• W1974802912 hasConceptScore W1974802912C2776174234 @default.
• W1974802912 hasConceptScore W1974802912C2777180221 @default.
• W1974802912 hasConceptScore W1974802912C2778653478 @default.
• W1974802912 hasConceptScore W1974802912C2779561371 @default.
• W1974802912 hasConceptScore W1974802912C2779922275 @default.
• W1974802912 hasConceptScore W1974802912C2780091579 @default.
• W1974802912 hasConceptScore W1974802912C2780259554 @default.
• W1974802912 hasConceptScore W1974802912C2780288358 @default.
• W1974802912 hasConceptScore W1974802912C2781184683 @default.
• W1974802912 hasConceptScore W1974802912C2908929049 @default.
• W1974802912 hasConceptScore W1974802912C555293320 @default.
• W1974802912 hasConceptScore W1974802912C71924100 @default.
• W1974802912 hasConceptScore W1974802912C84393581 @default.
• W1974802912 hasIssue "11" @default.
• W1974802912 hasLocation W19748029121 @default.
• W1974802912 hasLocation W19748029122 @default.
• W1974802912 hasOpenAccess W1974802912 @default.
• W1974802912 hasPrimaryLocation W19748029121 @default.
• W1974802912 hasRelatedWork W1965571951 @default.
• W1974802912 hasRelatedWork W2021055445 @default.
• W1974802912 hasRelatedWork W2033456799 @default.
• W1974802912 hasRelatedWork W2137999820 @default.
• W1974802912 hasRelatedWork W2353324822 @default.
• W1974802912 hasRelatedWork W2357929847 @default.
• W1974802912 hasRelatedWork W2359443551 @default.
• W1974802912 hasRelatedWork W2376102491 @default.
• W1974802912 hasRelatedWork W3148712325 @default.
• W1974802912 hasRelatedWork W4382010788 @default.
• W1974802912 hasVolume "16" @default.
• W1974802912 isParatext "false" @default.
• W1974802912 isRetracted "false" @default.
• W1974802912 magId "1974802912" @default.
• W1974802912 workType "article" @default.